Inhibiting mutant KRAS G12D gene expression using novel peptide nucleic acid‑based antisense: A potential new drug candidate for pancreatic cancer - Shai, A; Galouk, E; Miari, R; Tareef, H; Sammar, M; Zeidan, M; Rayan, A; Falah, M (Oncology Letters, 2022)